Dare Bioscience, Inc. Current Assets
Dare Bioscience, Inc. (DARE) had Current Assets of $16.69 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $16.69M.
- 2026-03-31: Assets, Current $21.66M.
- 2025-12-31: Assets, Current $27.06M.
- 2025-09-30: Assets, Current $25.00M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $16.69M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $21.66M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $27.06M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $25.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.60M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $11.82M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $18.45M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $14.95M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $20.83M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $9.98M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $17.54M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $22.44M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $22.24M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $29.51M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $43.04M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $49.57M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $50.11M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $47.82M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $55.30M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $48.24M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $14.06M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $9.60M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $6.98M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $6.98M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $7.78M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $9.32M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $6.44M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $3.24M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $6.56M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $4.26M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $7.24M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $10.17M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $12.82M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $15.94M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $8.35M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $10.38M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $39.41K 8-K/A · filed 2017-10-02 | $8.13M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $15.61M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $44.61K 10-K · filed 2018-03-28 | $36.79M 10-K · filed 2017-03-31 |
| 2016-09-30 | $39.20M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $48.92M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $62.10M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $469.41K 8-K/A · filed 2017-10-02 | $77.30M 10-K · filed 2016-03-10 |
| 2015-09-30 | $79.15M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $87.08M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $58.58M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $52.84M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $59.70M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $65.39M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $11.50M 10-Q · filed 2014-05-27 | |
| 2013-12-31 | $6.45M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |